Oncology Companion Diagnostic Market is likely to exhibit CAGR of 13.3%, and estimated to hit worth of USD 10.57 Billion by year 2032 end | PMR
The ability of companion diagnostics to facilitate early cancer detection and screening initiatives is a major trend supporting industry development. By technology analysis, the immunohistochemistry segment witnessed the largest revenue share in 2022. By region analysis, the Asia Pacific region is anticipated to experience significant growth.๐๐๐ฒ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข The global oncology companion diagnostic market was valued at USD 3.45 billion in 2023 and is expected to grow to USD 10.57 billion by 2032.
โข The industry is projected to grow at a compound annual growth rate (CAGR) of 13.3% over the estimated period of 2024 to 2032.
โข The market is primarily segmented based on offering, technology, disease type, end user, and region.
โข The major regions covered in the market report include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/industry-analysis/oncology-companion-diagnostic-market/request-for-sample
๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Oncology companion diagnostic is a medical device that offers information essential for the safe and effective use of targeted therapies. A companion diagnostic test is used to determine the treatment option a patient is likely to benefit from. To help determine the best treatment plan, data about the genomic alterations with the patient's tumor is considered. Companion diagnostics play a vital role in personalized medicine, enabling oncologists to choose the most appropriate treatment based on their unique genetic profile. Oncology companion diagnostic finds application in the treatment of various diseases, including melanoma, breast cancer, colorectal cancer, leukemia, and prostate cancer, amongst others.
๐๐๐ฃ๐จ๐ซ ๐๐๐ซ๐ญ๐ข๐๐ข๐ฉ๐๐ง๐ญ๐ฌ
โข The oncology companion diagnostic market is characterized by fragmentation. The industry has the presence of several key players who are constantly upgrading their technology to strengthen their market position. Among the major industry participants include:
โข Abbott Laboratories
โข Agilent Technologies
โข Bio-Rad Laboratories
โข Biocartis
โข Exact Sciences
โข Genedrive
โข Genomic Health
โข Guardant Health
โข Illumina
โข Invivoscribe
โข Myriad Genetics
โข QIAGEN
โข Roche Diagnostics
โข Sysmex Corporation
โข Thermo Fisher Scientific
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/3099/2
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ
โข The global rise in cancer incidence is a fundamental driver of the market. The rising prevalence of various cancer types highlights the need for advanced diagnostic tools that facilitate accurate patient stratification.
โข The rising availability of targeted cancer therapies is another factor that boosts market development. Companion diagnostics enable the delivery of highly effective treatments while minimizing the side effects linked to broad-spectrum approaches.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ญ๐๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/oncology-companion-diagnostic-market
๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐จ๐ง ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข Product segment held a significant share in 2022, owing to growing cancer prevalence, global aging population, and advancements in precision medicine
โข Immunohistochemistry emerged as the largest segment on account of its wide use in biomarker detection, subtype classification, and treatment guidance
โข The breast cancer segment is expected to experience significant growth during the forecast period, which is mainly driven by its growing adoption of targeted therapies and regulatory support
โข Hospitals segment held the maximum market revenue share in 2022, mainly for early detection and diagnosis, treatment monitoring, and patient-centric care
โข North America region dominated the market with majority share in 2022, owing to the rise of personalized medicine, regulatory framework, and partnerships and collaborations
๐๐จ๐ฉ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐๐ก๐๐ง๐๐๐๐๐๐ก๐๐ฉ๐๐ฉ๐๐ค๐ฃ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/telerehabilitation-market
๐๐ง๐๐ซ๐๐ฉ๐ ๐๐ช๐ง๐จ๐๐ฃ๐ ๐๐๐ง๐ซ๐๐๐๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/private-nursing-services-market
๐ผ๐ก๐ฅ๐ค๐ง๐ฉ ๐๐ฎ๐ฃ๐๐ง๐ค๐ข๐ ๐๐ง๐๐๐ฉ๐ข๐๐ฃ๐ฉ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/alport-syndrome-treatment-market
๐ผ๐ฃ๐๐ข๐๐ก ๐๐ก๐ฉ๐ง๐๐จ๐ค๐ช๐ฃ๐ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/animal-ultrasound-market
๐๐ฉ๐ค๐จ๐๐ค๐ฅ๐ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/otoscope-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Companion Diagnostic Market is likely to exhibit CAGR of 13.3%, and estimated to hit worth of USD 10.57 Billion by year 2032 end | PMR here
News-ID: 3482023 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Composites Market Expected to Witness Robust Growth, Forecasting US$ 173.84 Bill โฆ
The market was valued at USD 94.16 billion in 2023 and is expected to grow to 173.84 billion by 2032. The composites market is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032. In 2023, Asia Pacific conquered the market. Also, North America is expected to witness a major growth rate.
๐๐ง๐ฅ๐จ๐๐ค ๐๐ง๐ข๐ช๐ฎ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/composites-market/request-for-sample
Composites are simply an amalgamation of two orโฆ
Central Lab Market is anticipated to generate an estimated revenue of USD 5.55 b โฆ
Global central lab market size and share is currently valued at USD 3.20 billion in 2023 and is anticipated to generate an estimated revenue of USD 5.55 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Central Lab Market, a cutting-edge online platform designed toโฆ
Synthetic Lubricants Market Indicate to Reach US$ 56.92 Billion by 2032, Anticip โฆ
Polaris Market Research has recently published its latest analysis on the Synthetic Lubricants Market. The research states that the market for synthetic lubricants was estimated to be worth USD 42.53 billion in 2023. It is anticipated to grow to USD 56.92 billion by 2032, exhibiting a CAGR of 3.3% during the forecast period, 2024 to 2032.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/synthetic-lubricants-market/request-for-sample
A synthetic lubricant is a lubricant typeโฆ
Reading Glasses Market is predicted to expand to USD 61.04 billion by 2032, at a โฆ
Reading Glasses-Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global reading glasses market was estimated to be worth USD 36.87 billion in 2023 and is predicted to expand to USD 61.04 billion by 2032, with a CAGR of 5.8% during the forecast period 2024 to 2032.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/reading-glasses-market/request-for-sample
๐๐๐ฅ๐ค๐ง๐ฉ ๐๐๐ค๐ฅ๐:
This report is a comprehensive and detailed study of the global reading glasses industry. It provides anโฆ
More Releases for Oncology
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im โฆ
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications.
The research goes into great detail on several aspects that have been studied asโฆ
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco โฆ
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, โOncology Biosimilars Market Global Report 2020-30โ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It isโฆ
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summitโ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland andโฆ
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summitโ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland andโฆ
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summitโ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.
Allied Academies was founded by Jim and JoAnn Carland andโฆ
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summitโ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipatedโฆ